A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer

Clinical trial NCT01784913 · COMPLETED

Trial details

NCT number: NCT01784913
Sponsor: Ultimovacs ASA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2013-04-15
Primary completion: 2015-07-08
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.